Skip to content

Efficacy of Cardiac Resynchronization Therapy in Patients with Non-Left Bundle Branch Block type ECG: Multicenter Registry

Efficacy of Cardiac Resynchronization Therapy in Patients with Non-Left Bundle Branch Block type ECG: Multicenter Registry - non-LBBB CRT Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000057500
Enrollment
100
Registered
2025-04-08
Start date
2025-04-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure patients with non-left bundle branch block type ECG who meet the class IIa/IIb recommendation for cardiac resynchronization therapy (CRT) according to the Japanese guideline on non-pharmacological therapy of cardiac arrhythmias

Interventions

None listed

Sponsors

Fujita Health University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patient's age should be 20 y/o or more at the time of consent acquisition. 2. Therapeutic indication of cardiac resynchronization therapy should be based on the Japanese guideline (2018 JCS/JHRS non-pharmacological guideline). 3. QRS morphology should not meet the Strauss's criteria for left bundle branch block (LBBB). Strauss's Criteria for LBBB: 1. Intrinsic QRS duration >140 ms (men) or >130 ms (women). 2. QS or rS pattern in leads V1 and V2. 3. Notching or slurring in the mid-QRS complex in at least two of the following leads: V1, V2, V5, V6, I, and aVL.

Exclusion criteria

Exclusion criteria: 1. Patients who meet Class III indication of CRT in the Japanese guideline. 2. Patients with frequent recurrent ventricular tachycardia (VT) or ventricular fibrillation (VF) that cannot be controlled with antiarrhythmic drugs or catheter ablation. 3. Patients with severe drug-refractory congestive heart failure classified as NYHA functional class IV who are not candidates for heart transplantation, cardiac resynchronization therapy (CRT), or left ventricular assist device. 4. Patients who have refused the rPatients who have refused the registration to this study. 5. Patients who are made ineligible for this study by physicians. 6. Patients who have LBBB type ECG based on the Strauss's criteria.

Design outcomes

Primary

MeasureTime frame
The criteria for CRT responders (LVEF, LVESV, Clinical Composite Score)

Countries

Japan

Contacts

Public ContactMasahide Harada

Fujita Health University Department of Cardiology

mharada@fujita-hu.ac.jp0562932312

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026